News and Publications
Publication Categories
7 Hills Pharma Receives $2M SBIR Grant from NCI to Launch Phase 1 Trials of Lead Immunostimulant to Augment Immuno-Oncology Drugs, COVID-19 and Flu Vaccines
7 Hills Pharma receives a $2M SBIR grant from the National Cancer Institute (NCI) to support Phase 1 trials of 7HP349, a small molecule designed to enhance immuno-oncology drugs and vaccines for COVID-19 and flu.